Selective heart rate reduction with ivabradine slows ischaemia-induced electrophysiological changes and reduces ischaemia–reperfusion-induced ventricular arrhythmias

Journal of Molecular and Cellular Cardiology

Volumn 59, Issue , 2013, Pages 67-75

  Ng, Fu Siong ^a   Shadi, Iqbal T ^a   Peters, Nicholas S ^a   Lyon, Alexander R ^a,b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Heart rate reduction; Ischaemia reperfusion; Ivabradine; Reperfusion arrhythmias; Ventricular arrhythmias

Indexed keywords

IVABRADINE; ANTIARRHYTHMIC AGENT; BENZAZEPINE DERIVATIVE;

ADULT; ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIARRHYTHMIC ACTIVITY; ARTICLE; CONTROLLED STUDY; EPICARDIUM; EXPERIMENTAL CORONARY ARTERY OCCLUSION; HEART ATRIUM PACING; HEART CONDUCTION; HEART ELECTROPHYSIOLOGY; HEART MUSCLE EXCITABILITY; HEART MUSCLE FIBER MEMBRANE POTENTIAL; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; INCIDENCE; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MYOCARDIAL ISCHEMIA REPERFUSION INJURY; NONHUMAN; OPTICAL MAPPING; PRIORITY JOURNAL; RAT; REPERFUSION VENTRICULAR ARRHYTHMIA; ANIMAL; DRUG EFFECT; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HEART RATE; REPERFUSION INJURY; SPRAGUE DAWLEY RAT;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIAS, CARDIAC; BENZAZEPINES; HEART RATE; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; RATS; RATS, SPRAGUE-DAWLEY; VENTRICULAR FIBRILLATION;

EID: 84874944254     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2013.02.001     Document Type: Article

References (30)

1. Tennant, R., Wiggers, C., The effect of coronary occlusion on myocardial contraction. J Physiol 112 (1935), 351–361.
2. Tzivoni, D., Keren, A., Granot, H., Gottlieb, S., Benhorin, J., Stern, S., Ventricular fibrillation caused by myocardial reperfusion in Prinzmetal's angina. Am Heart J 105 (1983), 323–325.
3. Mehta, R., Harjai, K., Grines, L., Stone, G., Boura, J., Cox, D., et al. Sustained ventricular tachycardia or fibrillation in the cardiac catheterization laboratory among patients receiving primary percutaneous coronary intervention: incidence, predictors, and outcomes. J Am Coll Cardiol 43 (2004), 1765–1772.
4. Wit, A., Janse, M., Reperfusion arrhythmias and sudden cardiac death: a century of progress toward an understanding of the mechanisms. Circ Res 89 (2001), 741–743.
5. Kaplinsky, E., Ogawa, S., Michelson, E., Dreifus, L., Instantaneous and delayed ventricular arrhythmias after reperfusion of acutely ischemic myocardium: evidence for multiple mechanisms. Circulation 63 (1981), 333–340.
6. Corr, P., Witkowski, F., Potential electrophysiologic mechanisms responsible for dysrhythmias associated with reperfusion of ischemic myocardium. Circulation 68 (1983), I16–I24.
7. Shen, A.C., Jennings, R.B., Kinetics of calcium accumulation in acute myocardial ischemic injury. Am J Pathol 67 (1972), 441–452.
8. Bernier, M., Curtis, M., Hearse, D., Ischemia-induced and reperfusion-induced arrhythmias: importance of heart rate. Am J Physiol 256 (1989), H21–H31.
9. Tosaki, A., Szekeres, L., Hearse, D.J., Metoprolol reduces reperfusion-induced fibrillation in the isolated rat heart: protection is secondary to bradycardia. J Cardiovasc Pharmacol 10 (1987), 489–497.
10. van Gilst, W.H., de Graeff, P.A., Kingma, J.H., de Langen, C.D., Wesseling, H., Effects of diltiazem on reperfusion-induced arrhythmias in vitro and in vivo. J Mol Cell Cardiol 18 (1986), 1255–1266.
11. Zuanetti, G., De Ferrari, G.M., Priori, S.G., Schwartz, P.J., Protective effect of vagal stimulation on reperfusion arrhythmias in cats. Circ Res 61 (1987), 429–435.
12. Borer, J.S., Fox, K., Jaillon, P., Lerebours, G., Ivabradine Investigators Group. Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial. Circulation 107 (2003), 817–823.
13. Swedberg, K., Komajda, M., Böhm, M., Borer, J.S., Ford, I., Dubost-Brama, A., et al. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet 376 (2010), 875–885.
14. Fox, K., Ford, I., Steg, P.G., Tendera, M., Ferrari, R., BEAUTIFUL Investigators. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet 372 (2008), 807–816.
15. Fox, K., Ford, I., Steg, P.G., Tendera, M., Robertson, M., Ferrari, R., BEAUTIFUL Investigators. Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial. Lancet 372 (2008), 817–821.
16. Nakata, T., Hearse, D.J., Curtis, M.J., Are reperfusion-induced arrhythmias caused by disinhibition of an arrhythmogenic component of ischemia?. J Mol Cell Cardiol 22 (1990), 843–858.
17. Walker, M.J.A., Curtis, M.J., Hearse, D.J., Campbell, R.W.F., Janse, M.J., Yellon, D.M., et al. The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia, infarction, and reperfusion. Cardiovasc Res 22 (1988), 447–455.
18. Fedorov, V., Lozinsky, I., Sosunov, E., Anyukhovsky, E., Rosen, M., Balke, C., et al. Application of blebbistatin as an excitation–contraction uncoupler for electrophysiologic study of rat and rabbit hearts. Heart Rhythm 4 (2007), 619–626.
19. Laughner, J.I., Ng, F.S., Sulkin, M.S., Arthur, R.M., Efimov, I.R., Processing and analysis of cardiac optical mapping data obtained with potentiometric dyes. Am J Physiol Heart Circ Physiol 303 (2012), H753–H765.
20. Vaillant, F., Timour, Q., Descotes, J., Manati, W., Belhani, D., Bui-Xuan, B., et al. Ivabradine induces an increase in ventricular fibrillation threshold during acute myocardial ischemia: an experimental study. J Cardiovasc Pharmacol 52 (2008), 548–554.
21. Vaillant, F., Dehina, L., Mazzadi, A., Descotes, J., Chevalier, P., Tabib, A., et al. Heart rate reduction with ivabradine increases ischaemia-induced ventricular fibrillation threshold: role of myocyte structure and myocardial perfusion. Resuscitation 82 (2011), 1092–1099.
22. Bui-Xuan, B., Aupetit, J.F., Freysz, M., Loufoua, J., Faucon, G., Timour, Q., Cardiac beta-adrenoreceptor activation and ventricular fibrillation under normal and ischemic conditions. Cardiovasc Res 32 (1996), 1056–1063.
23. Aupetit, J.F., Frassati, D., Bui-Xuan, B., Freysz, M., Faucon, G., Timour, Q., Efficacy of a beta-adrenergic receptor antagonist, propranolol, in preventing ischaemic ventricular fibrillation: dependence on heart rate and ischaemia duration. Cardiovasc Res 37 (1998), 646–655.
24. Paur, H., Wright, P.T., Sikkel, M.B., Tranter, M.H., Mansfield, C., O'Gara, P., et al. High levels of circulating epinephrine trigger apical cardiodepression in a β2-adrenoceptor/Gi-dependent manner: a new model of takotsubo cardiomyopathy. Circulation 126 (2012), 697–706.
25. Heusch, G., Skyschally, A., Gres, P., van Caster, P., Schilawa, D., Schulz, R., Improvement of regional myocardial blood flow and function and reduction of infarct size with ivabradine: protection beyond heart rate reduction. Eur Heart J 29 (2008), 2265–2275.
26. Ceconi, C., Cargnoni, A., Francolini, G., Parinello, G., Ferrari, R., Heart rate reduction with ivabradine improves energy metabolism and mechanical function of isolated ischaemic rabbit heart. Cardiovasc Res 84 (2009), 72–82.
27. Akar, J., Akar, F., Regulation of ion channels and arrhythmias in the ischemic heart. J Electrocardiol 40 (2007), S37–S41.
28. Shaw, R., Rudy, Y., Electrophysiologic effects of acute myocardial ischemia. A mechanistic investigation of action potential conduction and conduction failure. Circ Res 80 (1997), 124–138.
29. Yellon, D., Hausenloy, D., Myocardial reperfusion injury. N Engl J Med 357 (2007), 1121–1135.
30. Akar, F.G., Aon, M.A., Tomaselli, G.F., O'Rourke, B., The mitochondrial origin of postischemic arrhythmias. J Clin Invest 115 (2005), 3527–3535.